Peringkat dalam Saham
#40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Kapitalisasi Pasar
$126.82K
Perubahan (1 tahun)
-21.82%
Perdagangan BioLineRx Ltd. (BLRX)
Harga BLRX dengan kapitalisasi pasar B
Kapitalisasi pasar dari BioLineRx Ltd.(BLRX)
Kapitalisasi Pasar: $126.82K
Per August 2026, BioLineRx Ltd. memiliki kapitalisasi pasar sebesar $126.82K. Ini menjadikan BioLineRx Ltd. sebagai perusahaan 40526th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar BioLineRx Ltd. dari 2007 hingga 2026
BLRX dibandingkan dengan 5 teratas stocks paling populer
| Harga BLRX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+4,312,917,893.90%
|
|
|
|
|
$4.467T
|
+3,522,438,642.46%
|
|
|
|
|
$4.174T
|
+3,291,646,617.50%
|
|
|
|
|
$3.700T
|
+2,917,637,670.26%
|
|
|
|
|
$2.854T
|
+2,250,746,944.65%
|
